Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
This research aims to compare two methods of early screening to identify infants at risk for Autism Spectrum Disorder and Neurodevelopmental Disorders. It targets infants under 12 months of age to provide early access to care, hoping to improve outcomes by detecting developmental delays compared to typical age expectations. The study is conducted at multiple Maternal and Child Protection Services in France and follows infants up to 48 months of age. Two screening approaches are evaluated during routine visits for vaccinations or developmental exams at 4 and 9 months. One method involves a health professional assessing neurodevelopment through routine observations of motor skills, vocalizations, babbling, and social interactions. The other method uses the PREAUT grid, a specific screening tool for autism spectrum disorders. Infants showing abnormal results are referred promptly to specialized centers for further advice and treatment when needed. Participants will have follow-ups at 12, 24, and 36 months including developmental assessments like the Modified Checklist for Autism in Toddlers and the Child Development Inventory. Additional diagnostic tools are used if initial tests indicate concerns. The study also collects data on treatments received, parental psychological state, quality of life, and family impact. Health insurance data will track care pathways up to 48 months. The main outcome is the proportion of children diagnosed and receiving care before age one.
Actively Recruiting
Researchers are evaluating two anesthesia approaches for patients undergoing hand surgery, focusing on reducing anxiety during the operation. This study compares the effects of adding neuroleptanalgesia or hypnoanalgesia to locoregional anesthesia. The main goal is to measure changes in anxiety levels before and after surgery using a visual scale. Secondary goals include comparing pain, surgery duration, hospital stay, sedative use, patient satisfaction, and side effects between the groups. Participants receive locoregional anesthesia by a trunk block and are randomly assigned to one of two groups. One group receives neuroleptanalgesic treatment with Hypnovel dosed by weight, while the other group undergoes hypnoanalgesia sessions led by a trained nurse using hypnosis techniques tailored to each patient. These treatments are administered during outpatient hand surgeries such as flexor tenosynovectomy or carpal tunnel release. During the study, participants will be assessed for anxiety and pain levels before, during, and after surgery, along with satisfaction and safety monitoring. The main outcome is the anxiety score on day 2 after surgery. Researchers will also track procedure duration, intensive care and hospital stay, additional sedative use, and any adverse events. Participation involves signing consent and attending scheduled evaluations until day 2 post-surgery.
Actively Recruiting
Researchers are conducting a French national observational study to evaluate patients with HER2-negative early breast cancer who are treated with olaparib. The study aims to understand how many patients complete the full adjuvant olaparib treatment in a real-world setting. This study observes patients receiving olaparib as part of their standard care without assigning treatments. Participants are those diagnosed with HER2-negative early breast cancer and starting adjuvant olaparib based on their physicians decision. The study does not provide or assign treatments but follows patients who are prescribed olaparib in routine clinical practice. There are no comparison groups or placebo treatments in this observational study. During the study, researchers will monitor patients for up to 18 months to measure the proportion who complete the full olaparib treatment course. They will also collect information on BRCA mutation characteristics, medical history, and the timing of treatment discontinuation. Participants will be observed through routine care without additional interventions, allowing researchers to assess real-world treatment adherence and outcomes.